CLINICAL_TRIALS
trial_result
· 2025-11-19
Clinical Trial Update: Cabozantinib and Pembrolizumab in Metastatic Pancreas [Phase 2]
Summary
A Phase 2 trial evaluating the combination of cabozantinib and pembrolizumab in metastatic pancreatic cancer has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Joseph Kim | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED | Results posted: 2025-11-19